Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus | Zendy

Keivan Zandi | Zendy; Franck Amblard | Zendy; Sarah Amichai | Zendy; Leda Bassit | Zendy; Sijia Tao | Zendy; Yong Jiang | Zendy; Longhu Zhou | Zendy; Olivia Ollinger Russell | Zendy; Seema Mengshetti | Zendy; Raymond F. Schinazi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus

Author(s) -

Keivan Zandi,

Franck Amblard,

Sarah Amichai,

Leda Bassit,

Sijia Tao,

Yong Jiang,

Longhu Zhou,

Olivia Ollinger Russell,

Seema Mengshetti,

Raymond F. Schinazi

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00889-19

Subject(s) - virology , yellow fever , flavivirus , virus , antiviral drug , outbreak , flaviviridae , zika virus , biology , viral disease

Yellow fever virus (YFV) is a humanFlavivirus reemerging in parts of the world. While a vaccine is available, large outbreaks have recently occurred in Brazil and certain African countries. Development of an effective antiviral against YFV is crucial, as there is no available effective drug against YFV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research